Eternal Youth Seeker Bryan Johnson Diagnosed with Incurable Autoimmune Disease
Translated from Finnish, summarized and contextualized by DistantNews.
At a glance
- Millionaire entrepreneur Bryan Johnson, known for pursuing eternal youth, has been diagnosed with an incurable autoimmune disease.
- Johnson, 48, revealed he has autoimmune gastritis, a condition where the body's immune system attacks the stomach lining.
- This diagnosis presents a setback to his extreme lifestyle focused on anti-aging and longevity.
Bryan Johnson, the 48-year-old tech mogul famous for his quest for eternal youth, has disclosed a new health challenge: an incurable autoimmune disease. Johnson announced in late June that he has been diagnosed with autoimmune gastritis, a condition characterized by the body's own immune mechanisms attacking the stomach lining.
Autoimmune gastritis can lead to various complications, including iron deficiency, and potentially increases the risk of cancer over the long term. This diagnosis marks a significant setback for Johnson's highly optimized lifestyle, which is meticulously designed to counteract the aging process and maximize longevity. His overarching goal is to live as long as possible.
In a 2023 interview with Helsingin Sanomat, Johnson detailed his "don't die" regimen, which included plasma transfusions from his son and stem cell treatments, all under daily monitoring by a team of doctors. He also markets supplements used in his protocol through his own website. However, professors interviewed by HS at the time expressed skepticism about his methods. A Netflix documentary about Johnson's pursuit of longevity, titled "Don't Die: The Man Who Wants to Live Forever," is slated for release in 2025.
Johnson himself attributes his current diagnosis to poor lifestyle choices in his youth, such as consuming sugar and fast food. Scientific understanding, however, suggests that genetic factors likely also play a role in the development of such conditions.
Originally published by Helsingin Sanomat in Finnish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.